Almon RR, Dubois DC, Yao Z, Hoffman EP, Ghimbovschi S, Jusko WJ. Microarray Analysis of Temporal Response of Skeletal Muscle to Methylprednisolone: Comparative Analysis of Two Dosing Regimens. Physiol Genomics. 2007. (Epub ahead of print)

Bonifati DM, Witchel SF, Ermani M, Hoffman EP, Angelini C, Pegoraro E. The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy. J Neurol Neurosurg Psychiatry. 77(10):1177-9, 2006.

Buyse GM, Goemans N, Henricson E, Jara A, van den Hauwe M, Leshner R, Florence JM, Mayhew JE, Escolar DM. CINRG pilot trial of oxatomide in steroid-naive Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2007. (Epub ahead of print)

Chen YW, Nagaraju K, Bakay M, McIntyre O, Rawat R, Shi R, Hoffman EP. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology. 65(6):826-34, 2005.

Devaney JM, Hoffman EP, Gordish-Dressman H, Kearns A, Zambraski E, Clarkson PM. Devaney JM, Hoffman EP, Gordish-Dressman H, Kearns A, Zambraski E, Clarkson PM. IGF-II gene region polymorphisms related to exertional muscle damage. J Appl Physiol. 102(5):1815-23, 2007.

Kostek MC, Chen YW, Cuthbertson DJ, Shi R, Fedele MJ, Esser KA, Rennie MJ. Gene expression responses over 24h to lengthening and shortening contractions in human muscle: major changes in CSRP3, MUSTN1, SIX1 and FBXO32. Physiol Genomics. 2007. (Epub ahead of print)

Seo J, Hoffman EP. Probe set algorithms: is there a rational best bet? BMC Bioinformatics. 30;7:395, 2007.

Seo J, Gordish-Dressman H, Hoffman EP.An interactive power analysis tool for microarray hypothesis testing and generation. Bioinformatics. 22(7):808-14, 2006.

Wang Z, Wang Y, Xuan J, Dong Y, Bakay M, Feng Y, Clarke R, Hoffman EP. Optimized multilayer perceptrons for molecular classification and diagnosis using genomic data. Bioinformatics. 22(6):755-61, 2006.

Yao Z, Zhao B, Hoffman EP, Ghimbovschi S, DuBois DC, Almon RR, Jusko WJ. Application of scaling factors in simultaneous modeling of microarray data from diverse chips. Pharm Res. 24(4):643-9, 2007.

University of Iowa

Barresi R and KP Campbell. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119:199-201, 2006.

Beedle A, Nienaber P, Campbell KP. Fukutin-related Protein Associates with the Sarcolemmal Dystrophin-Glycoprotein Complex. J Biol Chem 282(23):16713-7, 2007.

Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, Brown CA, Michele DE, Piccolo F, Winder TL, Stence A, Barresi R, King N, King W, Florence J, Campbell KP, Fenichel GM, Stedman HH, Kissel JT, Griggs RC, Pandya S, Mathews KD, Pestronk A, Serrano C, Darvish D, Mendell JR. Limb-girdle muscular dystrophy in the USA. J Neuropathol Exp Neurol 65:995-1003, 2006.

University of Pittsburgh

Draviam RA, Wang B, Li J, Xiao X, Watkins SC. Mini-dystrophin efficiently incorporates into the dystrophin protein complex in living cells. J Muscle Res Cell Motil 27(1): 53-67, 2006.

Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tobita K, Keller BB, Cummins JH, and J Huard. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12: 1130-41, 2005.

Payne TR, Oshima H, Sakai T, Ling Y, Gharaibeh B, Cummins J, and J Huard. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther 12: 1264-74, 2005.

Qiao C, Li J, Zhu T, Draviam R, Watkins S, Ye X, Chen C, Li J, and X Xiao. Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Proc Natl Acad Sci USA 102: 11999-2004, 2005.

University of Rochester

Tawil R, Van Der Maarel SM. Facioscapulohumeral muscular dystrophy. Muscle Nerve 34(1):1-15, 2006.

Kanadia RN, Shin J, Yuan Y, Beattie SG, Wheeler TM, Thornton CA , Swanson MS. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A 103(31):11748-53, 2006.

Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, and CA Thornton. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15: 2087-97, 2006.

Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, and TA Cooper. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci 118: 2923-33, 2005.

Ladd AN, Stenberg MG, Swanson MS, and TA Cooper. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn 233: 783-93, 2005.

Mankodi A, Lin X, Blaxall BC , Swanson MS, and CA Thornton. Nuclear RNA foci in the heart in myotonic dystrophy. Circ Res 97: 1152-5, 2005.

Yuan Y, Kanadia R, and MS Swanson. Impact of Unstable Microsatellites on RNA Processing. Chemtracts - Biochemistry and Molecular Biology 18: 129-140, 2005.

Leppert J , Urbinati CR , Hafner S , Ohlenschlager O , Swanson MS , Gorlach M , and R Ramachandran . Identification of NH...N hydrogen bonds by magic angle spinning solid state NMR in a double-stranded RNA associated with myotonic dystrophy. Nucleic Acids Res 32: 1177-83, 2004.

Ho TH, Charlet-B N, Poulos MG, Singh G, Swanson MS, and TA Cooper. Muscleblind proteins regulate alternative splicing. EMBO J 23: 3103-12, 2004.

Jiang H, Mankodi A, Swanson MS, Moxley RT, and CA Thornton. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 13: 3079-88, 2004.

Jun KY, Xia Y, Han X, Zhang H, Timchenko L, Swanson MS, and X Gao. (1)H, (15)N and (13)C chemical shift assignments of RNA repeats binding protein -- CUGBP1ab. J Biomol NMR 30: 371-2, 2004.

Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, and MS Swanson. A muscleblind knockout model for myotonic dystrophy. Science 302: 1978-80, 2003.

Kanadia RN, Urbinati CR, Crusselle VJ, Luo D, Lee YJ, Harrison JK, Oh SP, and MS Swanson. Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr Patterns 3: 459-62, 2003.

Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, and CA Thornton. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 54: 760-8, 2003.

University of Washington

Cho DH, Tapscott SJ. Myotonic dystrophy: Emerging mechanisms for DM1 and DM2. Biochim Biophys Acta, 2006. (Epub ahead of print)

Gaedigk R, Law DJ, Fitzgerald-Gustafson KM, McNulty SG, Nsumu NN, Modrcin AC, Rinaldi RJ, Pinson D, Fowler SC, Bilgen M, Burns J, Hauschka SD, White RA. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene. Neuromuscul Disord 16(3):192-203, 2006.

Gregorevic P, Allen JM, Minami E, Blankinship MJ, Haraguchi M, Meuse L, Finn E, Adams ME, Froehner SC, Murry CE, and JS Chamberlain. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12(7): 787-9, 2006.

Blankinship MJ, Gregorevic P, and JS Chamberlain. Gene therapy strategies for duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors. Mol Ther 13: 241-9, 2006.

Han JJ, Carter GT, Ra JJ, Abresch RT, Chamberlain JS, and LR Robinson. Electromyographic studies in mdx and wild-type C57 mice. Muscle Nerve 33: 208-14, 2006.

Cho DH, Thienes CP, Mahoney SE, Analau E, Filippova GN, Tapscott SJ. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell 20(3):483-9, 2005.

Li S, Kimura E, Fall BM, Reyes M, Angello JC, Welikson R, Hauschka SD, and JS Chamberlain. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther 12: 1099-108, 2005.

Liu M, Yue Y, Harper SQ, Grange RW, Chamberlain JS, and D Duan. Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol Ther 11: 245-56, 2005.

Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL, Miller DA, and JS Chamberlain. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 10: 671-8, 2004.

Dell'Agnola C, Wang Z, Storb R, Tapscott SJ, Kuhr CS, Hauschka SD, Lee RS, Sale GE, Zellmer E, Gisburne S, Bogan J, Kornegay JN, Cooper BJ, Gooley TA, and MT Little. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 104: 4311-8, 2004.

Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG, Russell DW, and JS Chamberlain. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10: 828-34, 2004.

Gregorevic P, Blankinship MJ, and JS Chamberlain. Viral vectors for gene transfer to striated muscle. Curr Opin Mol Ther 6: 491-8, 2004.

Baron F, Storb R, and M Little. Hematopoietic Cell Transplantation: Five Decades of Progress. Arch Med Res 34: 528-44, 2003.